Evidence map›Paper›PMID 40004749›Full record

ArticleJournal of clinical medicine2025

Clinically Accessible Liver Fibrosis Association with CT Scan Coronary Artery Disease Beyond Other Validated Risk Predictors: The ICAP Experience.

Belén García Izquierdo, Diego Martínez-Urbistondo, Sonsoles Guadalix, Marta Pastrana, Ana Bajo Buenestado, Inmaculada Colina, Manuel García de Yébenes, Gorka Bastarrika, José A Páramo, Juan Carlos Pastrana

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Belén García IzquierdoDepartment of Endocrinology, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-8124-4271
Diego Martínez-UrbistondoVascular Medicine Area, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Sonsoles GuadalixDepartment of Endocrinology, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Marta PastranaDepartment of Internal Medicine, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-1106-6684
Ana Bajo BuenestadoVascular Medicine Area, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Inmaculada ColinaDepartment of Internal Medicine, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Manuel García de YébenesDepartment of Cardiology, Clínica Universidad de Navarra, 28027 Madrid, Spain.
Gorka BastarrikaDepartment of Radiology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
José A PáramoDepartment of Hematology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-1497-6242
Juan Carlos PastranaVascular Medicine Area, Clínica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-1066-4551

Funding

Evidenze foundation Evidenze Foundation. InnovaRCV grant for CV risk research 2024
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atherosclerotic disease burdencardiovascular risk assessmentliver fibrosisobesitystatin use

Identifiers

PMID40004749
PMCPMC11856594

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.